FDA Accepts Supplemental Biologics License Applications for

/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the...

Related Keywords

Brussels , Bruxelles Capitale , Belgium , Smyrna , Izmir , Turkey , Erica Puntel , Antje Witte , Hidradenitis Suppurativa , Emmanuel Caeymaex , Group Of Companies , Drug Administration , Ucb Inc , Twitter , Immunology Solutions , Us Communications , Biologics License Application , Executive Vice President , Important Safety Information , United States , Herpes Simplex Infections , Euronext Brussels , Oral Presentation , Rev Dis , Clin Cosmet Investig , Its Effect , Study Participants With Moderate , Severe Hidradenitis Suppurativa , Ucb ,